Legal Representation
Attorney
Ilene B. Tannen
USPTO Deadlines
Application History
27 events| Date | Code | Type | Description |
|---|---|---|---|
| Nov 18, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Nov 18, 2024 | EXT3 | S | SOU EXTENSION 3 FILED |
| Nov 18, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 18, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 23, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED |
| May 23, 2024 | EXT2 | S | SOU EXTENSION 2 FILED |
| May 23, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 21, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 17, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Nov 17, 2023 | EXT1 | S | SOU EXTENSION 1 FILED |
| Nov 17, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 6, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 11, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 11, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 22, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 2, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 2, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 1, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 1, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 10, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 10, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Aug 10, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Aug 4, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 7, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Apr 6, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 4, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders
Class 042
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Class 044
Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases
Additional Information
Design Mark
The mark consists of the letters "NGM BIO" within a horizontal oval which contains a swooping stripe going through it on the right side.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"